Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen
<p>Abstract</p> <p>Background</p> <p>Synuclein gamma (SNCG), initially identified as a breast cancer specific gene, is aberrantly expressed in many different malignant tumors but rarely expressed in matched nonneoplastic adjacent tissues. In this study, we investigated...
Main Authors: | Xing Xiaofang, Qu Like, Lu Aiping, Dong Bin, Liu Caiyun, Meng Lin, Wu Jian, Eric Shi Y, Shou Chengchao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/359 |
Similar Items
-
Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion
by: Caiyun Liu, et al.
Published: (2018-06-01) -
Heterogeneous expression of carcinoembryonic antigen in the normal colon and upregulation in active ulcerative colitis.
by: Smithson, J, et al.
Published: (1996) -
Serum carcinoembryonic antigen tends to decrease in poorly-differentiated colorectal cancer
by: Ester Morina Silalahi, et al.
Published: (2015-12-01) -
Serum carcinoembryonic antigen tends to decrease in poorly-differentiated colorectal cancer
by: Ester Morina Silalahi, et al.
Published: (2013-12-01) -
High Prevalence of Abnormal Carcinoembryonic Antigen in Diabetic Inpatients with Poor Glycemic Control
by: Liu XY, et al.
Published: (2022-08-01)